Rhenman & Partners Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $16.1M | Sell |
|
|||||
|
2021
Q4 | $20.7M | Buy |
|
|||||
|
2021
Q3 | $18.8M | Sell |
|
|||||
|
2021
Q2 | $19.5M | Hold |
|
|||||
|
2021
Q1 | $13.7M | Sell |
|
|||||
|
2020
Q4 | $20.1M | Sell |
|
|||||
|
2020
Q3 | $20.2M | Buy |
|
|||||
|
2020
Q2 | $15.4M | Buy |
|
|||||
|
2020
Q1 | $4.76M | Buy |
|
|||||
|
2019
Q4 | $6.8M | Buy |
|